• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZENG Yi, ZHAO Cheng, WANG Fei, ZHU Qiuyan, XU Xiaole. Effects and mechanisms of stilbene glucoside on the proliferation and collagen synthesis of cardiac fibroblasts stimulated by TGF-β1[J]. Journal of China Pharmaceutical University, 2014, 45(3): 362-367. DOI: 10.11665/j.issn.1000-5048.20140320
Citation: ZENG Yi, ZHAO Cheng, WANG Fei, ZHU Qiuyan, XU Xiaole. Effects and mechanisms of stilbene glucoside on the proliferation and collagen synthesis of cardiac fibroblasts stimulated by TGF-β1[J]. Journal of China Pharmaceutical University, 2014, 45(3): 362-367. DOI: 10.11665/j.issn.1000-5048.20140320
shu

Effects and mechanisms of stilbene glucoside on the proliferation and collagen synthesis of cardiac fibroblasts stimulated by TGF-β1

More Information
    Graphical Abstract
    • Abstract
  • The aim of this study was to investigate the effect of stilbene glucoside(2, 3, 4′, 5-tetrahydroxystilbene-2-O-β-D glucoside, TSG)on the cell proliferation and collagen synthesis in cultured neonatal rat cardiac fibroblasts(CFBs)stimulated by transforming growth factor-β1(TGF-β1)and to explore the underlying mechanisms. CFB were cultured from neonatal rats of 1-3 days and treated with TGF-β1. CFB proliferation was analyzed by 5-bromo-2-deoxyuridine(BrdU)incorporation assay. The synthesis of collagen was examined by measurement of the hydroxyproline concentration. Flow cytometry used to examined cell cycle of CFBs treated with TSG. The expressions of α-smooth muscle actin, proliferating cell nuclear antigen(PCNA), collagen Ⅰ, collagen Ⅲ, p-Smad2, Smad2, p-Smad3, Smad3, p-ERK, ERK, p-P38, P38, p-JNK, JNK were measured by Western blot. The results of the present study showed that TSG(0. 1-100 μmol/L)to exerted no significant cytotoxicity on the cells. Within a concentration coverage, TSG inhibited CFB proliferation and collagen synthesis with inhibition of cell cycle transition from G0 /G1 phase to S phase. Furthermore, TSG decreased the protein expressions of PCNA, α-smooth muscle actin, collagen Ⅰ, Collagen Ⅲ, p-Smad3, p-ERK and p-P38 stimulated by TGF-β1. Taken together, TSG significantly inhibited CFB proliferation and collagen synthesis stimulated by TGF-β1, though, at least in part, by suppression of Smad3, ERK and P38 activation.
    • FullText(HTML)
    • References (15)
  • [1]
    Vasquez C,Benamer N,Morley GE.The cardiac fibroblast:functional and electrophysiological considerations in healthy and diseased hearts[J]. J Cardiovasc Pharmacol,2011,57(4):380-388.
    [2]
    Lim H,Zhu YZ.Role of transforming growth factor-beta in the progression of heart failure[J]. Cell Mol Life Sci,2006,63(22):2 584-296.
    [3]
    Zhang W,Wang CH,Li F,et al.2,3,4′,5-Tetrahydroxystilbene-2-O-beta-D-glucoside suppresses matrix metalloproteinase expression and inflammation in atherosclerotic rats[J]. Clin Exp Pharmacol Physiol 2008,35(3):310-316.
    [4]
    Cui HH,Tian Y,Long SY.The effective mechanism of 2,3,5,′4-tetrahydroxystilbene-2-O-β-D-glucoside in anti-atherosclerosis[J]. Prog Mod Biomed(现代生物医学进展),2009,9(20):3 968-3 971.
    [5]
    Zhang W,Xu XL,Wang YQ,et al.Effects of 2,3,4′,5-tetrahydroxystilbene 2-O-beta-D-glucoside on vascular endothelial dysfunction in atherogenic-diet rats[J]. Planta Med,2009,75(11):1 209-1 214.
    [6]
    Xu XL,Ling DY,Zhu QY,et al. The effect of 2,3,4′,5-tetrahydroxystilbene-2-O-β-D glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms[J]. Eur J Pharmacol 2013, 698(1/2/3):370-378.
    [7]
    Xu XL,Zhang W,Huang YJ,et al.Effect of 2,3,4′,5-tetrahydroxystilbene-2-O-β-D glucoside on vascular smooth muscle cells proliferation[J]. Chin Pharmacol Bull(中国药理学通报),2010,26(7):421-426.
    [8]
    Zhang SH,Wang WQ,Wang JL.Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo[J]. Acta Pharmacol Sin 2009,30(11):1 479-1 487.
    [9]
    Lajiness JD,Conway SJ.The dynamic role of cardiac fibroblasts in development and disease[J]. J Cardiovasc Transl Res,2012,5(6):739-748.
    [10]
    Edgley AJ,Krum H,Kelly DJ.Targeting fibrosis for the treatment of heart failure:a role for transforming growth factor-β[J]. Cardiovasc Ther,2012,30(1):e30-e40.
    [11]
    Gauldie J,Bonniaud P,Sime P,et al.TGF-beta,Smad3 and theprocess of progressive fibrosis[J].Biochem Soc Trans,2007,35(Pt 4):661-664.
    [12]
    Lan H Y,Chung AC.Transforming growth factor-β and Smads[J]. Contrib Nephrol,2011,170:75-82.
    [13]
    Mu Y,Gudey SK,Landstrom M.Non-Smad signaling pathways[J]. Cell Tissue Res,2012,347(1):11-20.
    [14]
    Gui T,Sun Y,Shimokado A,et al.The roles of mitogen-activated protein kinase pathways in TGF-β-Induced epithelial-mesenchymal transition[J]. J Signal Transduct.doi: 10.1155/2012/289243.
    [15]
    Wang Y.Mitogen-activated protein kinases in heart development and diseases[J]. Circulation,2007,116(12):1 413-1 423.
    • Related Articles

  • Related Articles

    [1]LIU Li, PEI Siran, WU Huali, ZHAO Qingshun, PENG Jixian, SHANG Jing. Drug screening model of treating pigmentation disorders in tyrp1a transgenic zebrafish[J]. Journal of China Pharmaceutical University, 2016, 47(6): 740-743. DOI: 10.11665/j.issn.1000-5048.20160618
    [2]SHAO Xin, YI Qianying, YANG Chunlei. Discovery of novel EphB4 inhibitors based on pharmacophore modeling and virtual screening techniques[J]. Journal of China Pharmaceutical University, 2016, 47(1): 38-47. DOI: 10.11665/j.issn.1000-5048.20160105
    [3]HE Hua, ZHANG Xue, WANG Yuhao, LIU Xiaoquan. Advances in pharmacokinetic and pharmacodynamic modeling of monoclonal antibody[J]. Journal of China Pharmaceutical University, 2015, 46(3): 279-288. DOI: 10.11665/j.issn.1000-5048.20150304
    [4]TANG Chunlei, HUANG Wenlong, QIAN Hai. Construction and application of 3D-pharmacophore model of glucokinase agonists[J]. Journal of China Pharmaceutical University, 2015, 46(2): 181-187. DOI: 10.11665/j.issn.1000-5048.20150208
    [5]HE Xiaobei, LIU Xiaodong. Physiologically based pharmacokinetic model of mechanism-based inhibition of theophylline/caffeine by enoxacin/ciprofloxacin[J]. Journal of China Pharmaceutical University, 2013, 44(1): 77-84. DOI: 10.11665/j.issn.1000-5048.20130113
    [6]REN Xin-yi, CHEN Yuan-cheng, WANG Yan, XIAO Yuan-yuan, LIU Xiao-quan. Pharmacokinetic-pharmacodynamic(PK-PD) modeling of salvianolic acid A on the plasma homocysteine in rats[J]. Journal of China Pharmaceutical University, 2012, 43(3): 260-265.
    [7]Linear Model for Prediction of Drug Shelf Life[J]. Journal of China Pharmaceutical University, 1999, (2): 69-72.
    [8]Yang Jinghua, Song Xiangzheng. The Markovian Model C in Pharmacokinetics[J]. Journal of China Pharmaceutical University, 1997, (1): 59-62.
    [9]Animal ECG Automatic Sample and Analysis-process by Computer[J]. Journal of China Pharmaceutical University, 1995, (5): 304-307.
    [10]Computer Program for the Effect Parameters of Combined Pharmacokinetic and Pharmacodynamic Model[J]. Journal of China Pharmaceutical University, 1990, (3): 142-146.

Catalog

    Get Citation
    PDF
    XML
    Article views (965) PDF downloads (1865) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：311835

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return